UW News
Q&A: How UW researchers are using AI to speed up drug discovery and development
## Speeding Up the Search: How UW Researchers are Harnessing AI for Drug Discovery
The path from a promising lab molecule to a life-saving drug is notoriously long and expensive, often taking over a decade and billions of dollars. But researchers at the University of Washington are working to dramatically shorten that timeline, leveraging the power of artificial intelligence. Housed within the UW School of Pharmacy, the Institute for Innovations in Drug Delivery and Disposition (I2D3) is a powerhouse, uniting experts across disciplines—AI specialists, drug discovery scientists, pharmacologists, data scientists, and biotechnology professionals—to tackle this critical bottleneck.
I2D3’s approach is fundamentally about accelerating the process. Traditionally, drug development relies on extensive trial and error. AI offers a new way, analyzing vast datasets to predict drug efficacy and safety, identifying promising candidates faster and more accurately. This targeted approach minimizes wasted resources and allows researchers to focus on the most likely breakthroughs.
The institute’s work represents a significant shift in how we approach drug development, with the potential to deliver treatments to patients more quickly. This is just one example of how AI is transforming scientific exploration; as seen in a recent collaboration focused on “UW researchers join national effort to streamline AI-driven cosmology,” the applications of this technology are rapidly expanding. Stay tuned for more insights into this exciting field.
